Literature DB >> 16760684

The Trial of Preventing Hypertension (TROPHY) as seen through the eyes of the Hypertension Writing Group's expanded definition of hypertension.

Thomas D Giles1.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16760684      PMCID: PMC8109600          DOI: 10.1111/j.1524-6175.2006.05673.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  4 in total

1.  Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Authors:  Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Journal:  N Engl J Med       Date:  2006-03-14       Impact factor: 91.245

2.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

3.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

4.  Expanding the definition and classification of hypertension.

Authors:  Thomas D Giles; Bradford C Berk; Henry R Black; Jay N Cohn; John B Kostis; Joseph L Izzo; Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-09       Impact factor: 3.738

  4 in total
  1 in total

1.  Prehypertension: an important preventive medicine concept--or marketing ploy?

Authors:  Barry J Materson
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-10       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.